Werewolf Therapeutics, Inc. (HOWL) quarterly income statement — complete revenue, gross profit & net income history
| Sales/Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.14M | 742K | 1.5M | 5.9M | 8.08M |
| Revenue Growth % | - | - | - | -100% | -100% | -100% | -100% | -85.86% | -83.38% | -79.39% | 18.65% | 94.82% |
| Cost of Goods Sold | 398K | 0 | 0 | 406K | 426K | 0 | 0 | 454K | 464K | 460K | 445K | 0 |
| COGS % of Revenue | - | - | - | - | - | - | - | 39.72% | 62.53% | 30.65% | 7.55% | - |
| Gross Profit | -398K | 0 | 0 | -406K | -426K | 0 | 0 | 689K | 278K | 1.04M | 5.45M | 8.08M |
| Gross Margin % | - | - | - | - | - | - | - | 60.28% | 37.47% | 69.35% | 92.45% | 100% |
| Gross Profit Growth % | 6.57% | - | - | -158.93% | -253.24% | -100% | -100% | -91.47% | -93.77% | 118.04% | 27.92% | 182.98% |
| Operating Expenses | 8.57M | 9.42M | 15.73M | 17.14M | 17.57M | 20.35M | 17.12M | 19.65M | 17.44M | 14M | 14.7M | 14.15M |
| OpEx % of Revenue | - | - | - | - | - | - | - | 1719.07% | 2350.4% | 932.91% | 249.33% | 175.08% |
| Selling, General & Admin | 5.09M | 2.48M | 4.09M | 4.4M | 4.87M | 4.62M | 4.6M | 4.38M | 4.53M | 4.35M | 4.31M | 4.57M |
| SG&A % of Revenue | - | - | - | - | - | - | - | 383.03% | 610.78% | 290.07% | 73.09% | 56.49% |
| Research & Development | 8.18M | 6.93M | 11.63M | 13.14M | 13.12M | 15.73M | 12.53M | 15.27M | 12.91M | 9.65M | 10.84M | 9.58M |
| R&D % of Revenue | - | - | - | - | - | - | - | 1336.05% | 1739.62% | 642.84% | 183.79% | 118.59% |
| Other Operating Expenses | -1000K | 0 | 0 | -406K | -426K | 0 | 0 | 0 | 0 | 0 | -445K | 0 |
| Operating Income | -8.97M | -9.42M | -15.73M | -17.54M | -17.99M | -20.35M | -17.12M | -18.96M | -17.16M | -12.96M | -9.25M | -6.07M |
| Operating Margin % | - | - | - | - | - | - | - | -1658.79% | -2312.94% | -863.56% | -156.88% | -75.08% |
| Operating Income Growth % | 50.16% | 53.72% | 8.16% | 7.48% | -4.83% | -56.98% | -85.1% | -212.51% | -40.41% | 1.65% | 26.22% | 59.48% |
| EBITDA | -8.57M | -9.02M | -15.32M | -17.14M | -17.57M | -19.91M | -16.67M | -18.51M | -16.7M | -12.5M | -8.81M | -5.63M |
| EBITDA Margin % | - | - | - | - | - | - | - | -1619.07% | -2250.4% | -832.91% | -149.33% | -69.71% |
| EBITDA Growth % | 51.22% | 54.7% | 8.07% | 7.4% | -5.19% | -59.22% | -89.3% | -228.53% | -41.53% | 2.04% | 25.57% | 61.91% |
| D&A (Non-Cash Add-back) | 398K | 400K | 402K | 406K | 426K | 442K | 454K | 454K | 464K | 460K | 445K | 434K |
| EBIT | -8.97M | -7.01M | -15.73M | -16.68M | -16.83M | -19.13M | -15.43M | -16.11M | -15.19M | -10.76M | -9.25M | -4.14M |
| Net Interest Income | -935K | -805K | -644K | -451K | -266K | 42K | 354K | 651K | 970K | 965K | 971K | 994K |
| Interest Income | 433K | 564K | 0 | 850K | 997K | 1.31M | 1.6M | 1.79M | 1.97M | 2.2M | 1.87M | 1.95M |
| Interest Expense | 1.37M | 1.37M | 644K | 1.3M | 1.26M | 1.27M | 1.24M | 1.14M | 1M | 1.24M | 900K | 955K |
| Other Income/Expense | -4.57M | 1.04M | -644K | -440K | -98K | -52K | 451K | 1.71M | 969K | 959K | 966K | 969K |
| Pretax Income | -13.53M | -8.38M | -16.37M | -17.98M | -18.09M | -20.4M | -16.67M | -17.25M | -16.19M | -12M | -8.29M | -5.1M |
| Pretax Margin % | - | - | - | - | - | - | - | -1509.1% | -2182.35% | -799.67% | -140.5% | -63.09% |
| Income Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Effective Tax Rate % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Net Income | -13.53M | -8.38M | -16.37M | -17.98M | -18.09M | -20.4M | -16.67M | -17.25M | -16.19M | -12M | -8.29M | -5.1M |
| Net Margin % | - | - | - | - | - | - | - | -1509.1% | -2182.35% | -799.67% | -140.5% | -63.09% |
| Net Income Growth % | 25.19% | 58.92% | 1.82% | -4.25% | -11.71% | -69.96% | -101.24% | -238.35% | -35.14% | -0.61% | 30.63% | 65.07% |
| Net Income (Continuing) | -13.53M | -8.38M | -16.37M | -17.98M | -18.09M | -20.4M | -16.67M | -17.25M | -16.19M | -12M | -8.29M | -5.1M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -0.28 | -0.17 | -0.36 | -0.40 | -0.40 | -0.46 | -0.38 | -0.40 | -0.39 | -0.33 | -0.23 | -0.14 |
| EPS Growth % | 30% | 63.04% | 5.26% | 0% | -2.56% | -39.39% | -65.22% | -185.71% | -14.71% | 5.71% | 39.47% | 73.08% |
| EPS (Basic) | -0.28 | -0.17 | -0.36 | -0.40 | -0.40 | -0.46 | -0.38 | -0.40 | -0.39 | -0.33 | -0.23 | -0.14 |
| Diluted Shares Outstanding | 49.39M | 46.81M | 45.8M | 44.98M | 44.83M | 44.48M | 43.7M | 43.52M | 41.61M | 36.57M | 35.65M | 35.56M |
| Basic Shares Outstanding | 48.6M | 46.02M | 45.47M | 44.98M | 44.83M | 44.48M | 43.7M | 43.52M | 41.61M | 36.57M | 35.65M | 35.56M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - | - | - |